Association of Serum Pyridoxal Phosphate Levels with Established Status Epilepticus
Resumen
The objective of this study was to determine the prevalence of pyridoxine deficiency, measured by pyridoxal phosphate (PLP) levels, in patients admitted to the hospital with established (benzodiazepine-resistant) status epilepticus (SE) (eSE) and to compare to three control groups: intensive care unit (ICU) patients without SE (ICU-noSE), non-ICU inpatients without SE (non-ICU), and outpatients with or without a history of epilepsy (outpatient).
Cómo citar
Rubinos, C., Bruzzone, M. J., Blodgett, C., Tsai, C., Patel, P., Hianik, R., Jadav, R., Boudesseul, J., Liu, C., Zhu, H., Wilson, S. E. & Olm-Shipman, C. (2023). Association of Serum Pyridoxal Phosphate Levels with Established Status Epilepticus. Neurocritical Care, 38(1), 41-51. https://doi.org/10.1007/s12028-022-01579-zEditor
SpringerCategoría / Subcategoría
PendienteTemas
Revista
Neurocritical CareISSN
1541-6933Coleccion(es)
- Investigadores externos [108]
El ítem tiene asociados los siguientes ficheros de licencia: